Austar Lifesciences Ltd. (HK:6118) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Austar Lifesciences Limited has scheduled a Board meeting on August 27, 2024, to review the Group’s unaudited financial results for the first half of the year and to consider the possibility of declaring an interim dividend. The meeting will be critical for shareholders looking to understand the company’s recent financial performance and dividend prospects.
For further insights into HK:6118 stock, check out TipRanks’ Stock Analysis page.